2020 Workshops - 5 February

The workshops are intimate 90-minute interactive education forums in which CXOs are navigated through considerations, strategy and ideas for approaching key company milestones by an expert partner. The workshops run throughout day two of the World Congress covering M&A, clinical strategies, licensing & collaboration and market access.

On registering, CXOs have the option to indicate their interest in attending up to two of the workshops. Seats will be allocated on a first come first served basis so register early to confirm your seat!

M&A Workshop 200x

The M&A Workshop is a 1.5hr intimate, interactive forum in which CEOs and CFOs navigate the how, what, where and when of a successful M&A. Delivering strategy, tactics, mechanics and ideas which are unique to a successful approach.

This workshop can be added as a free-to-attend agenda item. Limited places available.

Co-Hosts: 

CMS 300x150-1

Session led by:

Niall McAlister and Theo Godfrey of CMS Cameron McKenna Nabarro Olswang LLP

Draft Agenda: 

11:00
Introduction to M&A:
–       Key steps to consider when preparing the company for M&A
–      Share vs. asset sale
–      Due diligence and confidentiality
–      Exclusivity
–      Auctions
–      Warranty and indemnity insurance

11:30

Analysis of an M&A term sheet:
–      Warranties and limitations on liability
–      Escrow arrangements
–      Deferred/contingent consideration, including milestone payments and royalties
–      Non-cash consideration
–      Completion accounts vs. locked box
–      Restrictive covenants

12:00
Current Trends in M&A Deals

12:30
Close

Clinical Strategies Workshop 200x

Optimizing the Value: Insights into Product Development Strategies and Regulatory Pathways for Enhanced Asset Value

The clinical strategies workshop is a 1.5hr intimate, interactive forum in which a leading CRO partner hosts an intimate group of CxOs who are transitioning into clinical development and interested in exploring business models and approaches to partnerships in clinical trials.

This workshop can be added as a free-to-attend agenda item. Limited places available.

Co-Hosts: 

Premier Research 300x150

Draft Agenda: 

11.00
Optimizing the Value: Insights into Product Development Strategies and Regulatory Pathways for Enhanced Asset Value

Product Development and Regulatory Strategies for optimising your asset value

•       A Holistic Product Development Strategy:
–      Designing a target product profile that keeps the end in mind
–      Integrating statistical strategy early and often into a product development plan
–      Understanding the various stakeholders and their impact across the development lifecycle
–      Having a product development strategy that may include pediatric plan, statistical analysis plan, and target product profile adds value to your investment and optimizes the development pathway
•       Evaluating a Global Regulatory Strategy:
–      The value of presenting the various harmonization initiatives between the different regulatory agencies
–      Understanding what types of data can be leveraged across geographies
–      How to leverage the various “fast track” initiatives to develop and optimize your development plan

Speakers:

Colin Hayward, Chief Medical Officer, Premier Research
Nach Dave, Vice President, Development Strategy, Premier Research
Sameena Sharif, Senior Vice President, Product Development, RPI, a Division of Premier Research

12:30
Close
 

ENQUIRE HERE